​This anti GST-Eu cryptate is used in the HTRF® Kinase Binding format in combination with a GST-tagged Kinase and red-fluorescent tracers.

See more
  • No-wash No-wash
  • Ease-of-use Ease-of-use
  • High affinity High affinity

​This anti GST-Eu cryptate is used in the HTRF® Kinase Binding format in combination with a GST-tagged Kinase and red-fluorescent tracers.

-
In stock

Overview

MAb Anti GST-Eu cryptate Kinase Binding is an IgG2a raised against Glutathione S-transferase, labeled with Eu. It has been shown to react with GST-tagged kinases. 

This reagent is intended for use in the biochemical HTRF Kinase Binding platform.

Benefits

  • BATCH TO BATCH REPRODUCIBILITY
  • GST TAGGED ENZYME DETECTION

Kd determination assay principal

​The binding of the tracers is detected in a sandwich assay format using the Anti GST antibody labeled with Europium Cryptate (donor), which binds to the GST-tagged Kinase, and a red fluorescent tracer labelled with d2 (acceptor).

The detection principle is based on HTRF® technology. The HTRF ratio (665/620) will increase upon the addition of more of the tracer, and will saturate depending on the dissociation constant (Kd) of the tracer to the GST-tagged kinase. 

Principal of kinase binding saturation assay using anti-GST cryptate

Kd determination assay protocol

Saturation binding experiments on the three tracers (i.e. Staurosporine-Red, Dasatinib-Red, and Sunitinib-Red) can be run in 96- or 384-well plates (20 µL final volume).

First, a dilution series of tracer  ranging between 0 and 1  µM in the Kinase Binding Buffer is prepared in a 96-well non-binding plate. Next, 5 µL of Kinase Binding Buffer are dispensed into the final 96- or 384-well plate. Then 5 µL of GST tagged-Kinase are added, followed by 5 µL of Anti-GST Eu-cryptate. Finally, 5 µL of the red tracer solution are added. 

The HTRF ratio is measured after 1 H of incubation.

Protocol of kinase binding saturation assay using anti-GST cryptate

IC50/Ki determination assay principle

The binding of the tracers is detected in a sandwich assay format using the Anti-GST labeled with Europium Cryptate (donor), which binds to the tagged Kinase, and a red fluorescent tracer labelled with d2 (acceptor).

The detection principle is based on HTRF® technology.  The HTRF ratio (665/620) will increase upon the addition of more of the tracer, and will saturate depending on the dissociation constant (Kd ) of the tracer to the tagged kinase. When an inhibitor of the kinase is added, the tracer will be displaced and the HTRF signal will disappear, depending on the dose.

Principal of kinase binding inhibitor assay using anti-GST cryptate

IC50/Ki determination assay protocol

​Pharmacological evaluation of inhibitors of interest can be run in 96- or 384-well plates.

First, a dilution series of inhibitor ranging between 40 µM and 0.23 nM is prepared, and 5 µL of each concentration are dispensed into the plate. Next, 5 µL of tagged-Kinase are added, followed by 5 µL of anti-GST Eu-cryptate. Finally, 5 µL of tracer solution are added, prepared at 4x the final concentration.  The HTRF ratio is measured after 1H of incubation.

Analyses of the data give typical dose response curves ranging between 10 µM and 56 pM, enabling an evaluation of the IC50/Ki values for the inhibitor of interest.

Protocol of kinase binding inhibitor assay using anti-GST cryptate

Saturation Binding SRC-GST

​A typical saturation binding experiment is performed using final tracer concentrations between 0 and 250 nM, and measuring total- and non-specific binding signals. Subtracting the non-specific from the total binding signal gives the specific signal, which can be analysed to give the Kd. Here an example is shown where the best tracer for inhibitor studies proved to be Staurosporine-Red, with a Kd of 43 nM on 5 nM SRC-GST. ​​

Kd curves of Sunitinib-Red on SRC-GST

Competitive Binding FGFR1-GST

​​​Dose response curves of various known kinase inhibitors (Staurosporine, Dasatinib, PP2, Imatinib, Tozasertib, Sunitinib, Gefitinib, and Sorafenib) were measured using Staurosporine-Red at its Kd (29 nM) on 5 nM FGFR1-GST.  Staurosporine has an inihibition constant of 13 nM, in correlation with the literature value of 9.1 nM. Imatinib and Gefinitib do not compete, as can be expected for FGFR1.

 Inhibitor effect of various inhibitors on Staurosporine-red /FGFR1-GST binding
The ultimate guide to successful kinase binding experiments

Tips for getting the best performance from your Kinase binding assay - Guides

3 app notes on kinase inhibitor selection for kinase binding assays

Determine the best tracer to your kinase binding assay - Application Notes

Cisbio Product Catalog 2019

All your HTRF assays in one document! - Catalog

A guide to Homogeneous Time Resolved Fluorescence

General principles of HTRF - Guides

Product Insert Kin bind a-GST-Eu / 62KBGSTKAF-62KBGSTKABE

62KBGSTKAF-62KBGSTKABE - Product Insert

The essential white paper to expand your knowledge on kinases

Learn about cutting edge kinase research in this free white paper - Guides

How HTRF compares to Western Blot and ELISA

Get the brochure about technology comparison. - Brochures

How to run a Kinase Binding Platform assay

What to expect at the bench - Videos

tab6